当前位置:产品中心>单抗/多抗

Research Grade Davoceticept|Davoceticept(研究用级别)(靶标:Davoceticept融合蛋白)

货号:RB9T37016007
  • 价格:面议
  • 点击数:660
  

产品介绍

产品参数

形态Liquid
抗体亚型Fusion - [CD80 (B7-1, CD28LG1) fragment (1-107)]2
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Functional assay, Research in vivo
种属反应性Human
靶标B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, CD28, TP44, T-cell-specific surface glycoprotein
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号Q9NZQ7 & P10747 & P16410
背景信息Davoceticept (ALPN-202; CD80 vIgD-Fc) is a variant CD80 vIgD-Fc fusion protein targeting CTLA-4 and PD-L1. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells.<br>
别名ALPN-202, CD80vIgD-Fc, 2307144-64-3
备注For research use only. Not suitable for clinical or therapeutic use.